Global Opioid Induced Constipation (OIC) Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 149735
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 139
  • list Pharmaceuticals and Healthcare

Opioid-induced constipation (OIC) is a common adverse effect experienced by many patients on opioid therapy for chronic pain. OTC medications include stimulant laxatives, stool softeners, and enemas.

Scope of the Report:

The worldwide market for Opioid Induced Constipation (OIC) Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Opioid Induced Constipation (OIC) Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Ironwood Pharmaceuticals

Daiichi Sankyo Co

Pfizer

Progenics Pharmaceuticals

Shionogi &

Allergan

Nektar Therapeutics

Purdue Pharma

S.L.A. Pharma

Mundipharma International Limited

Ono Pharmaceutical

Takeda Pharmaceutical Company Limited

Theravance Biopharma

Valeant Pharmaceuticals International

Cosmo Pharmaceuticals SA

Daewoong Pharmaceutical

C.B. Fleet Company

Sucampo Pharmaceuticals

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Lubiprostone

Methyl Naltrexone Bromide

Naldemedine

Alvimopan

Other

Market Segment by Applications, can be divided into

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

There are 15 Chapters to deeply display the global Opioid Induced Constipation (OIC) Drug market.

Chapter 1, to describe Opioid Induced Constipation (OIC) Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Opioid Induced Constipation (OIC) Drug, with sales, revenue, and price of Opioid Induced Constipation (OIC) Drug, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Opioid Induced Constipation (OIC) Drug, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Opioid Induced Constipation (OIC) Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Opioid Induced Constipation (OIC) Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Opioid Induced Constipation (OIC) Drug Introduction

1.2 Market Analysis by Type

1.2.1 Lubiprostone

1.2.2 Methyl Naltrexone Bromide

1.2.3 Naldemedine

1.2.4 Alvimopan

1.2.5 Other

1.3 Market Analysis by Applications

1.3.1 Hospital Pharmacies

1.3.2 Retail Pharmacies

1.3.3 Online Pharmacies

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Ironwood Pharmaceuticals

2.1.1 Business Overview

2.1.2 Opioid Induced Constipation (OIC) Drug Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Daiichi Sankyo Co

2.2.1 Business Overview

2.2.2 Opioid Induced Constipation (OIC) Drug Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Pfizer

2.3.1 Business Overview

2.3.2 Opioid Induced Constipation (OIC) Drug Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Pfizer Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Progenics Pharmaceuticals

2.4.1 Business Overview

2.4.2 Opioid Induced Constipation (OIC) Drug Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Shionogi &

2.5.1 Business Overview

2.5.2 Opioid Induced Constipation (OIC) Drug Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Shionogi & Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Allergan

2.6.1 Business Overview

2.6.2 Opioid Induced Constipation (OIC) Drug Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Allergan Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Nektar Therapeutics

2.7.1 Business Overview

2.7.2 Opioid Induced Constipation (OIC) Drug Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Purdue Pharma

2.8.1 Business Overview

2.8.2 Opioid Induced Constipation (OIC) Drug Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 S.L.A. Pharma

2.9.1 Business Overview

2.9.2 Opioid Induced Constipation (OIC) Drug Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Mundipharma International Limited

2.10.1 Business Overview

2.10.2 Opioid Induced Constipation (OIC) Drug Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 Ono Pharmaceutical

2.11.1 Business Overview

2.11.2 Opioid Induced Constipation (OIC) Drug Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 Takeda Pharmaceutical Company Limited

2.12.1 Business Overview

2.12.2 Opioid Induced Constipation (OIC) Drug Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.13 Theravance Biopharma

2.13.1 Business Overview

2.13.2 Opioid Induced Constipation (OIC) Drug Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.14 Valeant Pharmaceuticals International

2.14.1 Business Overview

2.14.2 Opioid Induced Constipation (OIC) Drug Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Valeant Pharmaceuticals International Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.15 Cosmo Pharmaceuticals SA

2.15.1 Business Overview

2.15.2 Opioid Induced Constipation (OIC) Drug Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.16 Daewoong Pharmaceutical

2.16.1 Business Overview

2.16.2 Opioid Induced Constipation (OIC) Drug Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.17 C.B. Fleet Company

2.17.1 Business Overview

2.17.2 Opioid Induced Constipation (OIC) Drug Type and Applications

2.17.2.1 Product A

2.17.2.2 Product B

2.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.18 Sucampo Pharmaceuticals

2.18.1 Business Overview

2.18.2 Opioid Induced Constipation (OIC) Drug Type and Applications

2.18.2.1 Product A

2.18.2.2 Product B

2.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Opioid Induced Constipation (OIC) Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Opioid Induced Constipation (OIC) Drug Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Opioid Induced Constipation (OIC) Drug Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Opioid Induced Constipation (OIC) Drug Manufacturer Market Share in 2017

3.3.2 Top 6 Opioid Induced Constipation (OIC) Drug Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Opioid Induced Constipation (OIC) Drug Market Analysis by Regions

4.1 Global Opioid Induced Constipation (OIC) Drug Sales, Revenue and Market Share by Regions

4.1.1 Global Opioid Induced Constipation (OIC) Drug Sales and Market Share by Regions (2013-2018)

4.1.2 Global Opioid Induced Constipation (OIC) Drug Revenue and Market Share by Regions (2013-2018)

4.2 North America Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2013-2018)

4.3 Europe Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2013-2018)

4.5 South America Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2013-2018)

5 North America Opioid Induced Constipation (OIC) Drug by Countries

5.1 North America Opioid Induced Constipation (OIC) Drug Sales, Revenue and Market Share by Countries

5.1.1 North America Opioid Induced Constipation (OIC) Drug Sales and Market Share by Countries (2013-2018)

5.1.2 North America Opioid Induced Constipation (OIC) Drug Revenue and Market Share by Countries (2013-2018)

5.2 United States Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2013-2018)

5.3 Canada Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2013-2018)

5.4 Mexico Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2013-2018)

6 Europe Opioid Induced Constipation (OIC) Drug by Countries

6.1 Europe Opioid Induced Constipation (OIC) Drug Sales, Revenue and Market Share by Countries

6.1.1 Europe Opioid Induced Constipation (OIC) Drug Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Opioid Induced Constipation (OIC) Drug Revenue and Market Share by Countries (2013-2018)

6.2 Germany Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2013-2018)

6.3 UK Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2013-2018)

6.4 France Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2013-2018)

6.5 Russia Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2013-2018)

6.6 Italy Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2013-2018)

7 Asia-Pacific Opioid Induced Constipation (OIC) Drug by Countries

7.1 Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Opioid Induced Constipation (OIC) Drug Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Opioid Induced Constipation (OIC) Drug Revenue and Market Share by Countries (2013-2018)

7.2 China Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2013-2018)

7.3 Japan Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2013-2018)

7.4 Korea Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2013-2018)

7.5 India Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2013-2018)

8 South America Opioid Induced Constipation (OIC) Drug by Countries

8.1 South America Opioid Induced Constipation (OIC) Drug Sales, Revenue and Market Share by Countries

8.1.1 South America Opioid Induced Constipation (OIC) Drug Sales and Market Share by Countries (2013-2018)

8.1.2 South America Opioid Induced Constipation (OIC) Drug Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2013-2018)

8.3 Argentina Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2013-2018)

8.4 Colombia Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2013-2018)

9 Middle East and Africa Opioid Induced Constipation (OIC) Drug by Countries

9.1 Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2013-2018)

9.3 UAE Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2013-2018)

9.4 Egypt Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2013-2018)

9.5 Nigeria Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2013-2018)

9.6 South Africa Opioid Induced Constipation (OIC) Drug Sales and Growth Rate (2013-2018)

10 Global Opioid Induced Constipation (OIC) Drug Market Segment by Type

10.1 Global Opioid Induced Constipation (OIC) Drug Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Opioid Induced Constipation (OIC) Drug Sales and Market Share by Type (2013-2018)

10.1.2 Global Opioid Induced Constipation (OIC) Drug Revenue and Market Share by Type (2013-2018)

10.2 Lubiprostone Sales Growth and Price

10.2.1 Global Lubiprostone Sales Growth (2013-2018)

10.2.2 Global Lubiprostone Price (2013-2018)

10.3 Methyl Naltrexone Bromide Sales Growth and Price

10.3.1 Global Methyl Naltrexone Bromide Sales Growth (2013-2018)

10.3.2 Global Methyl Naltrexone Bromide Price (2013-2018)

10.4 Naldemedine Sales Growth and Price

10.4.1 Global Naldemedine Sales Growth (2013-2018)

10.4.2 Global Naldemedine Price (2013-2018)

10.5 Alvimopan Sales Growth and Price

10.5.1 Global Alvimopan Sales Growth (2013-2018)

10.5.2 Global Alvimopan Price (2013-2018)

10.6 Other Sales Growth and Price

10.6.1 Global Other Sales Growth (2013-2018)

10.6.2 Global Other Price (2013-2018)

11 Global Opioid Induced Constipation (OIC) Drug Market Segment by Application

11.1 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Application (2013-2018)

11.2 Hospital Pharmacies Sales Growth (2013-2018)

11.3 Retail Pharmacies Sales Growth (2013-2018)

11.4 Online Pharmacies Sales Growth (2013-2018)

12 Opioid Induced Constipation (OIC) Drug Market Forecast (2018-2023)

12.1 Global Opioid Induced Constipation (OIC) Drug Sales, Revenue and Growth Rate (2018-2023)

12.2 Opioid Induced Constipation (OIC) Drug Market Forecast by Regions (2018-2023)

12.2.1 North America Opioid Induced Constipation (OIC) Drug Market Forecast (2018-2023)

12.2.2 Europe Opioid Induced Constipation (OIC) Drug Market Forecast (2018-2023)

12.2.3 Asia-Pacific Opioid Induced Constipation (OIC) Drug Market Forecast (2018-2023)

12.2.4 South America Opioid Induced Constipation (OIC) Drug Market Forecast (2018-2023)

12.2.5 Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Forecast (2018-2023)

12.3 Opioid Induced Constipation (OIC) Drug Market Forecast by Type (2018-2023)

12.3.1 Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Type (2018-2023)

12.3.2 Global Opioid Induced Constipation (OIC) Drug Market Share Forecast by Type (2018-2023)

12.4 Opioid Induced Constipation (OIC) Drug Market Forecast by Application (2018-2023)

12.4.1 Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Application (2018-2023)

12.4.2 Global Opioid Induced Constipation (OIC) Drug Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Opioid Induced Constipation (OIC) Drug Picture

Table Product Specifications of Opioid Induced Constipation (OIC) Drug

Figure Global Sales Market Share of Opioid Indu

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery